News Story: Full Text
Sponsored By
Gamma Tiles
Please Click On The Above Banner For More Details
Braintumor Website


Pharmacyclics Reports Positive Clinical Results With Xcytrin for Treatment Of Brain Tumors and Other Cancers at ASCO Meeting (PR Newswire)Pharmacyclics, Inc. today reported results from several clinical trials with its lead product, Xcytrin(R) Injection, demonstrating that the investigational agent is well tolerated and may have clinical utility in a variety of cancers, including glioblastoma multiforme, childhood gliomas, pancreatic cancer and brain metastases, i.e., tumors that have spread to the brain from another part of the body.- May 14 9:01 AM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557